Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EIDD-1931 (Beta-d-N4-hydroxycytidine) is a ribonucleoside analog with antiviral activity.It inhibits replication of severe acute respiratory syndrome coronavirus (SARS-CoV) in Vero 76 cells, Middle East respiratory syndrome coronavirus (MERS-CoV) in Calu-3 2B4 cells, and SARS-CoV-2 in Vero cells (IC50s =0.1, 0.15 and 0.3 μM, respectively)
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 7,500 | |||
5 mg | 在庫あり | ¥ 17,500 | |||
10 mg | 在庫あり | ¥ 27,000 | |||
25 mg | 在庫あり | ¥ 45,500 | |||
50 mg | 在庫あり | ¥ 66,500 | |||
100 mg | 在庫あり | ¥ 95,000 | |||
500 mg | 在庫あり | ¥ 216,500 |
説明 | EIDD-1931 (Beta-d-N4-hydroxycytidine) is a ribonucleoside analog with antiviral activity.It inhibits replication of severe acute respiratory syndrome coronavirus (SARS-CoV) in Vero 76 cells, Middle East respiratory syndrome coronavirus (MERS-CoV) in Calu-3 2B4 cells, and SARS-CoV-2 in Vero cells (IC50s =0.1, 0.15 and 0.3 μM, respectively) |
別名 | Beta-d-N4-hydroxycytidine |
分子量 | 259.22 |
分子式 | C9H13N3O6 |
CAS No. | 3258-02-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (173.6 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EIDD-1931 3258-02-4 DNA Damage/DNA Repair Microbiology/Virology Proteases/Proteasome Virus Protease HCV Protease SARS-CoV Topoisomerase Chikungunya equine Enterovirus HEV HRV b-d-N4-hydroxycytidine Hepatitis C virus Beta-d-N4-hydroxycytidine Inhibitor CHIKV EIDD1931 β-d-N4-hydroxycytidine Enterovirus,VEEV HEVs NHC Rhinovirus HCV encephalitis EIDD 1931 inhibit venezuelan HRVs SARS coronavirus inhibitor